EnerSyn Global (ESYN) vs Cellyan Biotechnology (HKPD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
EnerSyn Global is the larger company by market cap ($61.5 million vs $4.7 million), about 13.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | ESYN | HKPD |
|---|---|---|
| Share price | $2.07 | $0.0955 |
| Market cap | $61.53M | $4.71M |
| 1-day change | -2.36% | -7.91% |
| YTD return | +38.26% | — |
| 1-year return | -27.21% | — |
| EPS (TTM) | $-0.39 | $-0.07 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.81 | $1.72 |
| 52-week low | $0.88 | $0.095 |
| Distance from 52-week high | -26.33% | -94.44% |
| Average volume | 162.03K | 3.77M |
| Shares outstanding | 29.73M | 42.17M |
| Sector | Health Care | Health Care |
| Industry | Other Pharmaceuticals | Other Pharmaceuticals |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- EnerSyn Global is about 13.1 times larger than Cellyan Biotechnology by market value ($61.53M vs $4.71M).
ESYN vs HKPD FAQ
Which is bigger, EnerSyn Global or Cellyan Biotechnology?
EnerSyn Global (ESYN) is larger, with a market capitalization of $61.53M compared with $4.71M for Cellyan Biotechnology (HKPD).
Are EnerSyn Global and Cellyan Biotechnology in the same industry?
Yes. Both are classified in the Other Pharmaceuticals industry within the Health Care sector.